ASGN [ASGN] vs Concentrix [CNXC] Detailed Stock Comparison

ASGN Inc.

NYSE
Loading...

Concentrix Corporation

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: ASGN Inc. wins in 9 metrics, Concentrix Corporation wins in 11 metrics, with 0 ties. Concentrix Corporation appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric ASGN Inc. Concentrix Corporation Better
P/E Ratio (TTM) 15.60 8.30 Concentrix Corporation
Price-to-Book Ratio 0.94 0.58 Concentrix Corporation
Debt-to-Equity Ratio 68.78 204.04 ASGN Inc.
PEG Ratio -0.40 -0.12 Concentrix Corporation
EV/EBITDA 7.57 5.77 Concentrix Corporation
Profit Margin (TTM) 2.85% -13.34% ASGN Inc.
Operating Margin (TTM) 6.83% 6.21% ASGN Inc.
EBITDA Margin (TTM) 6.83% 6.21% ASGN Inc.
Return on Equity 6.34% -38.92% ASGN Inc.
Return on Assets (TTM) 4.60% 3.17% ASGN Inc.
Free Cash Flow (TTM) $288.10M $572.47M Concentrix Corporation
Dividend Yield N/A 6.59% N/A
1-Year Return -57.05% -49.46% Concentrix Corporation
Price-to-Sales Ratio (TTM) 0.44 0.16 Concentrix Corporation
Enterprise Value $2.75B $7.10B Concentrix Corporation
EV/Revenue Ratio 0.69 0.71 ASGN Inc.
Gross Profit Margin (TTM) 28.93% 33.98% Concentrix Corporation
Revenue per Share (TTM) $92 $160 Concentrix Corporation
Earnings per Share (Diluted) $2.60 $-21.07 ASGN Inc.
Beta (Stock Volatility) 0.89 0.50 Concentrix Corporation
Short % of Float 13.26% 22.90% ASGN Inc.

ASGN Inc. vs Concentrix Corporation Stock Performance Analysis

Loading Price Chart...

ASGN
CNXC

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
ASGN Inc.-3.32%20.46%9.54%-43.37%-48.88%-50.28%
Concentrix Corporation-2.91%9.96%21.18%-10.32%-21.73%-30.87%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
ASGN Inc.-57.05%-67.25%-77.28%-39.47%127.25%87.59%
Concentrix Corporation-49.46%-68.46%-80.95%-64.64%-64.64%-64.64%

Performance & Financial Health Analysis: ASGN Inc. vs Concentrix Corporation

MetricASGNCNXC
Market Information
Market Cap i$833.93M$1.60B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i591,8741,388,202
90 Day Avg. Volume i918,8381,768,987
Last Close$22.43$27.66
52 Week Range$16.90 - $60.75$22.05 - $62.14
% from 52W High-63.08%-55.49%
All-Time High$131.89 (Jan 03, 2022)$208.48 (Feb 07, 2022)
% from All-Time High-82.99%-86.73%
Growth Metrics
Quarterly Revenue Growth-0.01%0.05%
Quarterly Earnings Growth-0.41%-0.69%
Financial Health
Profit Margin (TTM) i0.03%-0.13%
Operating Margin (TTM) i0.07%0.06%
Return on Equity (TTM) i0.06%-0.39%
Debt to Equity (MRQ) i68.78204.04
Cash & Liquidity
Book Value per Share (MRQ)$43.26$45.85
Cash per Share (MRQ)$3.90$3.65
Operating Cash Flow (TTM) i$327.90M$722.34M
Levered Free Cash Flow (TTM) i$251.94M$517.13M
Dividends
Last 12-Month Dividend Yield iN/A6.59%
Last 12-Month Dividend iN/A$1.74

Valuation & Enterprise Metrics Analysis: ASGN Inc. vs Concentrix Corporation

MetricASGN (Apr 24, 2026)CNXC (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i15.608.30
Forward P/E i6.932.09
PEG Ratio i-0.40-0.12
Price to Sales (TTM) i0.440.16
Price to Book (MRQ) i0.940.58
Market Capitalization
Market Capitalization i$833.93M$1.60B
Enterprise Value i$2.75B$7.10B
Enterprise Value Metrics
Enterprise to Revenue i0.690.71
Enterprise to EBITDA i7.575.77
Risk & Other Metrics
Beta i0.890.50
Book Value per Share (MRQ) i$43.26$45.85

Financial Statements Comparison: ASGN Inc. vs Concentrix Corporation

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricASGN (2025)CNXC (2025)
Revenue/Sales i3.98B9.83B
Cost of Goods Sold i2.83B6.39B
COGS % of Revenue i71.1%65.0%
Gross Profit i1.15B3.44B
Gross Margin i28.9%35.0%
Research & Development iN/AN/A
Operating Income (EBIT) i230.30M609.54M
Operating Margin i5.8%6.2%
EBITDA i343.80M1.30B
EBITDA Margin i8.6%13.2%
Pre-Tax Income i162.60M-1.18B
Pre-Tax Income % of Revenue i4.1%-12.0%
Income Tax i49.10M96.70M
Income Tax % of Revenue i1.2%1.0%
Net Income (Profit) i113.50M-1.28B
Profit Margin i2.9%-13.0%

Balance Sheet & Liquidity Metrics

MetricASGN (2025)CNXC (2025)
Cash & Equivalents i161.20M327.35M
Total Current Assets i916.20M3.08B
Total Current Assets % of Revenue i23.0%31.4%
Total Current Liabilities i424.30M2.20B
Total Current Liabilities % of Revenue i10.7%22.4%
Long-Term Debt i1.17B4.57B
Long-Term Debt % of Revenue i29.4%46.5%
Total Shareholders Equity i1.80B2.74B
Retained Earnings i1.09B-177.01M
Retained Earnings % of Revenue i27.4%-1.8%
Property, Plant & Equipment i00

Cash Flow Statement Comparison

MetricASGN (2025)CNXC (2025)
Operating Cash Flow i319.80M-739.00M
Operating Cash Flow % of Revenue i8.0%-7.5%
Capital Expenditures i-39.80M-234.50M
Free Cash Flow i288.10M572.47M
FCF Margin i7.2%5.8%
Debt Repayment i-282.30M-4.28B
Common Stock Repurchase i-170.10M-188.71M

Short Interest & Institutional Ownership Analysis

MetricASGNCNXC
Shares Short i3.20M11.88M
Short Ratio i3.006.77
Short % of Float i13.26%22.90%
Shares Outstanding i41.70M60.82M
Float Shares i39.91M42.39M
% Held by Insiders i4.07%16.15%
% Held by Institutions i104.30%102.83%
% Held by Public i-8.37%-18.98%

Dividend Analysis & Yield Comparison: ASGN Inc. vs Concentrix Corporation

MetricASGNCNXC
Last 12-Month Dividend iN/A$1.74
Last 12-Month Dividend Yield iN/A6.59%
3-Year Avg Annual Dividend iN/A$1.39
3-Year Avg Dividend Yield iN/A0.65%
3-Year Total Dividends iN/A$4.16
Ex-Dividend DateN/AApr 24, 2026